eoadjuvant chemotherapy and radiotherapy for operable breast cancer
Phase 2
- Conditions
- breast cancer
- Registration Number
- JPRN-UMIN000004460
- Lead Sponsor
- Osaka Medical Center for Cancer and Cardiovascular Diseases
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 35
Inclusion Criteria
Not provided
Exclusion Criteria
1) past history of any invasive malignancy within the previous 5 years 2) past history of breast cancer or synchronous bilateral breast cancer 3) past history of radiotherapy for ipsilateral breast 4) Suspicious of allergy for radiotherapy 5) Suspicious of allergy for paclitaxel, 5FU, epirubicin or cyclophosphamide 7) Patients during uncontrollable diabetes or psychologic disorder 8) Patients who have grade3-4 neuropathy 9) Pregnant or breast-feeding 10) Any reason the physician believes that the patient is not appropriate to participate in the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method